Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Picloxydine is a bisbiguanide antiseptic and antibacterial agent primarily used in ophthalmic solutions for the treatment of superficial ocular infections and trachoma. It is structurally similar to chlorhexidine and exhibits broad-spectrum bactericidal or bacteriostatic activity against both Gram-positive and Gram-negative bacteria. Its mechanism of action involves disruption of bacterial cell membranes by interacting with the lipid bilayer, leading to leakage of cellular contents and bacterial death. Picloxydine is most commonly formulated as eye drops (notably under the brand name Vitabact) for topical use in ophthalmology[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on picloxydine.